Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Feb;79(4):2079-86.
doi: 10.1128/JVI.79.4.2079-2086.2005.

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3

Martin Spiegel  1 , Andreas Pichlmair, Luis Martínez-Sobrido, Jerome Cros, Adolfo García-Sastre, Otto Haller, Friedemann Weber
Affiliations

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3

Martin Spiegel et al. J Virol. 2005 Feb.

Abstract

Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus termed SARS-CoV. We and others have previously shown that the replication of SARS-CoV can be suppressed by exogenously added interferon (IFN), a cytokine which is normally synthesized by cells as a reaction to virus infection. Here, we demonstrate that SARS-CoV escapes IFN-mediated growth inhibition by preventing the induction of IFN-beta. In SARS-CoV-infected cells, no endogenous IFN-beta transcripts and no IFN-beta promoter activity were detected. Nevertheless, the transcription factor interferon regulatory factor 3 (IRF-3), which is essential for IFN-beta promoter activity, was transported from the cytoplasm to the nucleus early after infection with SARS-CoV. However, at a later time point in infection, IRF-3 was again localized in the cytoplasm. By contrast, IRF-3 remained in the nucleus of cells infected with the IFN-inducing control virus Bunyamwera delNSs. Other signs of IRF-3 activation such as hyperphosphorylation, homodimer formation, and recruitment of the coactivator CREB-binding protein (CBP) were found late after infection with the control virus but not with SARS-CoV. Our data suggest that nuclear transport of IRF-3 is an immediate-early reaction to virus infection and may precede its hyperphosphorylation, homodimer formation, and binding to CBP. In order to escape activation of the IFN system, SARS-CoV appears to block a step after the early nuclear transport of IRF-3.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Absence of IFN-β induction in SARS-CoV-infected cells. (a) IFN-β promoter activation. Human 293 cells were transfected with plasmid p-125Luc containing the firefly luciferase gene under control of the IFN-β promoter, along with a control plasmid encoding Renilla luciferase under control of the constitutively active simian virus 40 promoter. At 6 h posttransfection, cells were infected with SARS-CoV or the IFN-inducing control virus Bunyamwera delNSs (CTRL) or left uninfected (mock). At 18 h postinfection, luciferase activities were measured. Firefly luciferase values (reflecting IFN-β promoter activation) were normalized to the Renilla luciferase activities. (b) Reverse transcription-PCR analysis. Total RNA from 293 cells which were infected for 18 h was assayed by reverse transcription-PCR for the presence of IFN-β mRNA (panel 1), mRNA of the N gene of SARS-CoV (panel 2) or the control virus (panel 3), or cellular γ-actin mRNA (panel 4).
FIG. 2.
FIG. 2.
Subcellular localization of IRF-3 early in infection. Confocal double immunofluorescence pictures of cells which were either mock infected (panels 1 to 3) or infected for 8 h with SARS-CoV (panels 4 to 6) or the control virus (panels 7 to 9). Viral N proteins (panels 4 and 7) and IRF-3 (panels 2, 5, and 8) were detected with specific rabbit and mouse antisera, respectively.
FIG. 3.
FIG. 3.
Subcellular localization of IRF-3 late in infection. Cells were infected for 16 h and immunostained as indicated for Fig. 2.
FIG. 4.
FIG. 4.
Hyperphosphorylation of IRF-3. Extracts from cells infected for 8 h (a) or 16 h (b) were analyzed by sodium dodecyl sulfate gel electrophoresis, followed by immunoblot analyses to detect IRF-3 (panels 1), the N protein of SARS-CoV (panels 2), or the N protein of the control virus (panels 3). The two forms of unphosphorylated IRF-3 are indicated by arrowheads, and the hyperphosphorylated form of IRF-3 is indicated by an asterisk (*).
FIG. 5.
FIG. 5.
Homodimerization of IRF-3. Extracts from cells infected with SARS-CoV or the control virus for 8 h (a) or 16 h (b) were analyzed by nondenaturing gel electrophoresis followed by an immunoblot to detect IRF-3. The positions of IRF-3 monomers and dimers are indicated by arrowheads.
FIG. 6.
FIG. 6.
CBP recruitment by IRF-3. Cells were infected for 8 h (a) or 16 h (b), and anti-CBP immunocomplexes (IP) were analyzed for the presence of IRF-3 (panels 1) and CBP (panels 2). Infections were monitored by probing the postprecipitation supernatants (SN) for the viral N proteins (panels 3 and 4).
FIG. 7.
FIG. 7.
Nuclear import and export. (a) Nuclear localization of IRF-2. Cells were transfected with plasmid pEGFP-C1-hIRF-2 for 24 h and then superinfected with SARS-CoV for 16 h (right panel) or left uninfected (left panel). Viral N protein was detected with a specific rabbit antiserum and a Cy3-conjugated secondary antibody. (b) Nuclear export assays. Cells were transfected with the Rev expression construct pcRev, the Rev export-dependent CAT reporter plasmid pDM128 (19), and the Renilla luciferase control plasmid pRL-SV40. After 4 h at 37°C, cells were either infected with SARS-CoV or left uninfected (black columns). As a control, cells were treated in parallel with the CRM-1 inhibitor leptomycin B (LMB) at a concentration of 2 ng/ml (grey columns). At 16 h postinfection, reporter activities were measured. CAT activities were normalized to the corresponding Renilla luciferase activities to determine induction. Data from a representative experiment are shown.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aurisicchio, L., P. Delmastro, V. Salucci, O. G. Paz, P. Rovere, G. Ciliberto, N. La Monica, and F. Palombo. 2000. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis. J. Virol. 74:4816-4823. - PMC - PubMed
    1. Baigent, S. J., G. Zhang, M. D. Fray, H. Flick-Smith, S. Goodbourn, and J. W. McCauley. 2002. Inhibition of β interferon transcription by noncytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism. J. Virol. 76:8979-8988. - PMC - PubMed
    1. Basler, C. F., and A. Garcia-Sastre. 2002. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 21:305-337. - PubMed
    1. Basler, C. F., A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Muhlberger, M. Bray, H. D. Klenk, P. Palese, and A. Garcia-Sastre. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956. - PMC - PubMed
    1. Baudoux, P., L. Besnardeau, C. Carrat, P. Rottier, B. Charley, and H. Laude. 1998. Interferon alpha inducing property of coronavirus particles and pseudoparticles. Adv. Exp. Med. Biol. 440:377-386. - PubMed

Publication types

MeSH terms

LinkOut - more resources

-